Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762320 · ClinicalTrials.gov registry record · NA
Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
A NA study, sponsored by Phoenix Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00762320 is a NA study that has completed, run by Phoenix Children's Hospital. The registered enrollment target is 8 participants.
The verdict
NCT00762320, a NA study, has completed, sponsored by Phoenix Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Kaletra (a combination drug with lopinavir and ritonavir) is one of a few effective medications that are approved and available for young children who are HIV+. The liquid form is reported to have a very nasty taste and presents difficulties for the children who must take the medication twice a day and for their parents who must enforce the medication regimen. The children are often well into their teens before they weigh enough to be able to take the adult dose tablet (200mg/50mg). A new smaller dose tablet (100mg/25mg) is now available. However, it is not known if the liquid and tablet act the same in children. The purpose of this study is to switch children from the baseline treatment with the liquid to the study intervention treatment with 100mg/25mg tablet form of Kaletra. The study will compare children pre-switch and post-switch in terms of how well their HIV is controlled . Comparisons of parent and child satisfaction will also be made. Eight to 10 HIV+ children currently well managed with a medications including liquid Kaletra will be invited to switch from the liquid to the low dose Kaletra tablet. The parent and/or child will complete a satisfaction survey for the liquid Kaletra and lab values will be taken from the chart. At the time of the switch and 1, 3 and 6 months post switch blood tests will be drawn and the parent and/or child will complete the satisfaction survey. In addition, at the switch and 1 month post switch, a day will be spent in clinic with 5 blood draws to see how much of the drug is in the blood stream at different times after the medicine is taken.
Interventions
- DRUG Low dose Kaletra tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00762320
The ClinicalTrials.gov registry entry for NCT00762320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phoenix Children's Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low dose Kaletra tablets is the first listed.
NCT00762320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00762320 about?
NCT00762320 is a clinical study titled "Comparison of Liquid Kaletra and Low Dose Kaletra Tablets". Kaletra (a combination drug with lopinavir and ritonavir) is one of a few effective medications that are approved and available for young children who are HIV+. The liquid form is reported to have a very nasty taste and presents difficulties for the children who must take the medication twice a day ...
What is the current status of trial NCT00762320?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2008-10. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00762320?
The interventions under investigation include: Low dose Kaletra tablets (DRUG).
Who is sponsoring clinical trial NCT00762320?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.